Skip to search formSkip to main contentSkip to account menu

dihydroergovaline

Known as: (5' alpha)-9,10-dihydro-12'-hydroxy-2'- methyl-5'-(1-methylethyl)ergotaman-3',6',18-trione 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1976
1976
The venoconstrictor effect of dihydroergotamine in man was demonstrated by Rieckert and Pauschinger in 1967. In a study on the…